Clinical Trial Update: Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ergocalciferol for iron metabolism in chronic kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• ergocalciferol (ergocalciferol)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: CKD, Chronic Kidney Diseases | Phase 4 | Status: WITHDRAWN